Condition
HR+ Breast Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 4 HR+ Breast Cancer clinical trials that are recruiting, at sites in 2 countries (most in United States (2), China (2)). By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest HR+ Breast Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SHY-ONC6: a new anti-cancer drug tested in adults with advanced solid tumors | Phase 1 | Scottsdale, Arizona and 2 other locations | Recruiting | Jul 15, 2026 |
| SC-101 in NECTIN4-amplified cancers | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Jul 23, 2025 |
| NKT5097 for adults with advanced or metastatic solid tumors. | Phase 1 | Duarte, California and 18 other locations | Recruiting | Jun 19, 2025 |
| Combination therapy using Anlotinib for HR+ metastatic breast cancer | — | Changsha, Hunan | Recruiting | Dec 16, 2024 |
All recruiting trials (4)
-
SHY-ONC6: a new anti-cancer drug tested in adults with advanced solid tumors
This early-phase study tests SHY-ONC6 to see if it is safe and can help people with advanced solid tumors after standard therapies have failed.
-
SC-101 in NECTIN4-amplified cancers
This study tests SC-101 as a stand-alone treatment in adults with NECTIN4 amplification and advanced or metastatic TNBC, HR+ breast cancer, or other solid tumors to see if it can shrink tumors and be safe.
-
NKT5097 for adults with advanced or metastatic solid tumors.
This trial tests an oral drug called NKT5097 in adults with advanced or metastatic solid tumors—especially certain breast cancers and tumors with CCNE1 amplification—to see if it is safe and shows anti‑tumor activity.
-
Combination therapy using Anlotinib for HR+ metastatic breast cancer
This study is testing a new combination treatment with anlotinib for women with hormone receptor-positive metastatic breast cancer who haven’t had success with other therapies.
Related topics
Quick answers
How many HR+ Breast Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.